HPV self-collection program for cervical cancer screening
HPV Self-Collection Program
This study tests a new program that lets women overdue for cervical cancer screening collect their own samples at home or in the clinic to see if it helps them get screened more easily and follow up on any positive HPV results.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 25 Years to 65 Years |
| Sex | Female |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Trial ID | NCT06674681 on ClinicalTrials.gov |
What this trial studies
This program aims to develop and implement HPV self-collection protocols for women overdue for cervical cancer screening. It includes both in-clinic and home-based options for self-collection, allowing women to choose how they want to participate in screening. The initiative will also provide educational resources to inform participants about HPV and cervical cancer, as well as instructions on using the self-collection kits. The goal is to improve screening rates and follow-up care for HPV-positive results in community health settings.
Who should consider this trial
Good fit: Ideal candidates for this program are women and individuals with a cervix aged 25-65 who are overdue for cervical cancer screening.
Not a fit: Patients without a cervix or those receiving hospice or palliative care may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly increase cervical cancer screening rates among women who are overdue for testing.
How similar studies have performed: Other studies have shown success with self-collection approaches for cervical cancer screening, indicating potential for this program's effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women and individuals with a cervix. * Aged 25-65 years during the study measurement period. * Qualifying visit to the participating clinic. * Overdue for cervical cancer screening. * Those aged 24-64 who have not had cervical cytology (i.e., Pap test) performed within the last three and a half (3.5) years, or those aged 30-65 who have not had cervical HPV testing (i.e., primary HPV testing or contesting for HPV with Pap test) performed within the last five and a half (5.5) years. Exclusion Criteria: * Individuals without a cervix. * Receiving hospice and/or palliative care during any part of the measurement period.
Where this trial is running
Salt Lake City, Utah
- University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Principal investigator: Deanna Kepka, PhD, MPH — University of Utah
- Study coordinator: Deanna Kepka
- Email: Deanna.Kepka@hci.utah.edu
- Phone: 801-587-4565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.